Cytosorbents Corporation · NASDAQ:CTSO
Avenue Capital Management II, L.P. reported a 5.70% stake in Cytosorbents Corporation (Schedule 13G)
Event Jun 26, 2024 · Filed May 28, 2025
Avenue Capital Management II, L.P. reported a 5.70% stake in Cytosorbents Corporation, 3,755,273 shares, as a passive investor on Jun 26, 2024. Filed May 28, 2025 (Schedule 13G).
- Stake
- 5.70%
- Shares
- 3,755,273
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avenue Venture Opportunities Fund, L.P. | 1.70% | 1,126,582 |
| Avenue Venture Opportunities Fund II, L.P. | 4.00% | 2,628,691 |
| Avenue Capital Management II, L.P. | 5.70% | 3,755,273 |
| Avenue Venture Opportunities Partners, LLC | 1.70% | 1,126,582 |
| Avenue Venture Opportunities Partners II, LLC | 4.00% | 2,628,691 |
| GL Venture Opportunities Partners, LLC | 1.70% | 1,126,582 |
| GL Venture Opportunities Partners II, LLC | 4.00% | 2,628,691 |
| Marc Lasry | 5.70% | 3,755,273 |